Core Insights - Avricore Health Inc. is launching a pilot program to deliver inclisiran cholesterol-lowering injections through community pharmacies in collaboration with Barts Health NHS Trust, UCL Partners, and the British Heart Foundation [1][3][6] Group 1: Pilot Program and Funding - The pilot is supported by a £198,000 grant from the British Heart Foundation, aiming to decentralize cardiovascular therapy delivery and reduce hospital burden by shifting services to community pharmacies [3] - The initiative is part of the ELoPE-CVD program, which focuses on expanding access to preventive heart care and optimizing lipid management for high-risk patients [3] Group 2: HealthTab Integration - HealthTab™ is integrated with the Ortus-iHealth platform, allowing pharmacy-generated results to flow directly into hospital clinical systems, enhancing connectivity and data availability for clinicians and patients [4][11] - This integration positions HealthTab as a core infrastructure for NHS pharmacy-based care, moving beyond diagnostics to support therapy initiation and monitoring [7][12] Group 3: Expansion of HealthTab's Role - The pilot marks a significant expansion of HealthTab's role from primary prevention to secondary prevention, enabling community pharmacies to deliver and monitor advanced lipid-lowering therapy for patients with existing cardiovascular disease [5][10] - HealthTab is now positioned as a trusted technology partner within a high-profile cardiovascular program, validating its effectiveness in long-term lipid management pathways [7][10] Group 4: NHS Goals and Community Pharmacy Involvement - The NHS aims to prevent up to 150,000 heart attacks, strokes, and dementia cases over the next decade by improving detection and management of high-risk conditions, including high cholesterol [9] - The initiative aligns with NHS policy to enhance the role of community pharmacies in managing long-term conditions and integrating them into shared digital records [9][10] Group 5: Commitment to Quality and Performance - HealthTab is designed to meet high standards of analytical performance and reliability, supported by a comprehensive quality management program in partnership with CEQAL Inc. [15][16] - The program includes centralized monitoring of reagents and regular quality assessments to ensure accuracy and consistency of results across participating sites [16]